1. Home
  2. ALAR vs LUNG Comparison

ALAR vs LUNG Comparison

Compare ALAR & LUNG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Alarum Technologies Ltd.

ALAR

Alarum Technologies Ltd.

HOLD

Current Price

$8.10

Market Cap

62.1M

Sector

Technology

ML Signal

HOLD

Logo Pulmonx Corporation

LUNG

Pulmonx Corporation

HOLD

Current Price

$1.44

Market Cap

57.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ALAR
LUNG
Founded
2013
1995
Country
Israel
United States
Employees
N/A
N/A
Industry
Computer Software: Prepackaged Software
Industrial Specialties
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
62.1M
57.9M
IPO Year
2018
2020

Fundamental Metrics

Financial Performance
Metric
ALAR
LUNG
Price
$8.10
$1.44
Analyst Decision
Strong Buy
Buy
Analyst Count
1
7
Target Price
$14.00
$5.38
AVG Volume (30 Days)
89.8K
567.9K
Earning Date
05-28-2026
04-29-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
7.64
EPS
N/A
N/A
Revenue
N/A
$90,497,000.00
Revenue This Year
$24.51
$2.48
Revenue Next Year
$33.43
$18.46
P/E Ratio
$44.31
N/A
Revenue Growth
N/A
8.01
52 Week Low
$5.50
$1.13
52 Week High
$18.00
$3.88

Technical Indicators

Market Signals
Indicator
ALAR
LUNG
Relative Strength Index (RSI) 43.15 54.31
Support Level $6.65 $1.39
Resistance Level $10.43 $1.45
Average True Range (ATR) 0.63 0.11
MACD -0.22 0.00
Stochastic Oscillator 13.86 74.60

Price Performance

Historical Comparison
ALAR
LUNG

About ALAR Alarum Technologies Ltd.

Alarum Technologies Ltd is a software-as-a-service (SaaS) provider operating mainly in the web data collection market, offering web data collection and a private internet browsing platform. The company's Web Data Collection products offer secure, fast, and anonymous IP Proxy Network Solutions & Services, or IPPN or IPPN Solutions, to its business customers which, in turn, enables them to anonymously and securely browse the internet as well as to collect data from any publicly available source on the web, for their business purpose. The company operates in one segment: web data collection. Geographically, it derives maximum revenue from China, followed by the United States, Europe, Hong Kong, Asia-Pacific, U.K. Virgin Islands, Israel, United Arab Emirates, Middle East & Africa and other.

About LUNG Pulmonx Corporation

Pulmonx Corp is a commercial-stage medical technology company that provides a minimally invasive treatment for patients with severe emphysema, a form of chronic obstructive pulmonary disease (COPD). solution, which is comprised of the Zephyr Endobronchial Valve (Zephyr Valve), the Chartis Pulmonary Assessment System (Chartis System), and the LungTraX Platform, is designed to treat severe emphysema patients who, despite medical management, are still profoundly symptomatic and either do not want or are ineligible for surgical approaches. The majority of the company's revenue is generated from the provision of cloud hosting and management services. The company geographically, operates in the USA, the EMEA, the Asia Pacific, and other international regions, the majority of revenue from USA.

Share on Social Networks: